60 Degrees Pharmaceuticals (SXTP) Partners With GoodRx to Expand Access to ARAKODA

Core Insights - 60 Degrees Pharmaceuticals Inc. has partnered with GoodRx to improve the affordability and accessibility of ARAKODA, the only FDA-approved once-weekly malaria prevention medication in the US [1][6] - The partnership allows eligible patients to save up to 30% on ARAKODA at over 70,000 pharmacies nationwide [1] Company Strategy - This initiative is part of the company's strategy to reduce out-of-pocket costs for international travelers going to malaria-endemic regions [2] - ARAKODA was developed by the Walter Reed Army Institute of Research and has a long terminal half-life of approximately 16 days, supporting its weekly dosing schedule [2] Treatment Regimen - The treatment involves a three-day loading phase before travel, followed by weekly doses during the stay and a final dose upon return [3] - The drug is a significant advancement in malaria prevention, a life-threatening disease transmitted by the Anopheles mosquito [3] Safety Protocols - The company emphasizes strict safety protocols, requiring G6PD deficiency testing for all patients before prescription to mitigate the risk of hemolytic anemia [3] Company Overview - 60 Degrees Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing therapies for infectious diseases in the US, specifically offering ARAKODA for malaria prevention [4]